Universal-Beteiligungs- und Servicegesellschaft’s Soleno Therapeutics SLNO Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-17,048	Closed	-$571K	–	2189
2026 Q1	$571K	Buy	17,048 +274	+2%	+$10.7K	﹤0.01%	1680
2025 Q4	$777K	Buy	16,774 +5,333	+47%	+$292K	﹤0.01%	1575
2025 Q3	$773K	Sell	11,441 -32,627	-74%	-$2.42M	﹤0.01%	1627
2025 Q2	$3.69M	Buy	44,068 +7,573	+21%	+$567K	0.01%	950
2025 Q1	$2.61M	Buy	+36,495	New	+$1.78M	0.01%	1058

Universal-Beteiligungs- und Servicegesellschaft's SLNO Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 17,048 shares — an estimated $571K sold.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in SLNO in Q1 2025 and held it in 5 quarters. The position peaked at $3.69M in Q2 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Universal-Beteiligungs- und Servicegesellschaft reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Universal-Beteiligungs- und Servicegesellschaft sold 17,048 Soleno Therapeutics shares in Q2 2026, an estimated $571K.
Universal-Beteiligungs- und Servicegesellschaft first reported a position in Soleno Therapeutics in Q1 2025 and held it in 5 quarters.
Universal-Beteiligungs- und Servicegesellschaft's Soleno Therapeutics position peaked at $3.69M in Q2 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.